Cardona GH, Argilagos CG, Mourlot RA, Bonne LJM, Martínez AG

Language: Spanish
References: 8
Page:
PDF size: 174.97 Kb.

ABSTRACT

Introduction: Coronavirus disease 2019 (COVID-19) is an acute respiratory infection caused by SARS-CoV-2, which can potentially cause severe acute respiratory syndrome and cause the death of the patient.
Objective: To present a patient with COVID -19 associated with aggravated preeclampsia, in a preterm pregnant woman.
Clinical case: A 25-year-old patient with a gestation of 35.2 weeks, a history of apparent health that was received since her arrival at the intensive care unit, referred for being positive for COVID-19, with respiratory symptoms of an associated lung disease, as high blood pressure figures, without other symptoms. Through physical examination and complementary humoral studies, an aggravated preeclampsia and oligohydramnios were diagnosed due to rupture of the ovular membranes. She was treated and compensated; Induction was started and during the procedure a risk of loss of fetal well-being was diagnosed, so it was decided to perform an urgent cesarean section. A healthy newborn was received. The patient did not present post-surgical complications and was treated according to current standards for cases of severe mother with COVID-19; she had a favorable evolution.
Conclusions: The early diagnosis and treatment of a pregnant woman with COVID-19 and associated preeclampsia allows a satisfactory evolution of the mother-fetus binomial.

REFERENCES

1. Centro de Medicina fetal-neonatal de Barcelona. Protocolo: Coronavirus (COVID-19) y gestación (V14 21/7/2021). España. 2021 [acceso: 22/09/2021]. Disponible en: Disponible en: https://medicinafetalbarcelona.org/protocolos/es/patologia-materna-obstetrica/covid19-embarazo.pdf 1.

2. Martínez-González B, Garza-Reséndez N, Contreras-Garza NY. Combinación de riesgo: COVID-19 y preeclampsia. Serie de casos y revisión bibliográfica. Ginecol Obstet Mex. 2021 [acceso: 22/09/2021]; 89(08):622-634. Disponible en: Disponible en: https://www.medigraphic.com/pdfs/ginobsmex/gom-2021/gom218f.pdf 2.

3. Smith V, Seo D, Warty R, Payne O, Salih M. Maternal and neonatal outcomes associated with COVID-19 infection. A systematic review. PLoS ONE. 2020 [acceso: 22/09/2021]; 15(6): e0234187. Disponible en: Disponible en: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0234187 3.

4. Cruz-Lemini M, Ferriols Perez E, de la Cruz Conty ML, Caño Aguilar A, Encinas Pardilla MB. Obstetric Outcomes of SARS-CoV-2 Infection in Asymptomatic Pregnant Women. Viruses. 2021 [acceso: 22/09/2021]; 13(1):112. Disponible en: Disponible en: https://www.mdpi.com/1999-4915/13/1/112 4.

5. Nápoles Méndez D, del Puerto Cruz A, Rodríguez García E, Piloto Padrón M, Castillo González D, Lim Alonso N. Principales emergencias obstétricas que causan ingreso en las unidades de cuidados intensivos. La Habana: Editorial Ciencias Médicas, 2021. [acceso: 22/09/2021]. Disponible en: Disponible en: http://www.bvs.sld.cu/libros/principales_emergencias_obstetricas/principales_emergencias_obstetricas.pdf 5.

6. Rodríguez-Brito A, Pérez D. OliveraCovid-19 y oportunidades para el bienestar materno-infantil en Cuba. Interface - Comunicação, Saúde, Educação. 2021 [acceso: 22/09/2021]; 25(Supl1): e200589. Disponible en: Disponible en: https://www.scielosp.org/pdf/icse/2021.v25suppl1/e200589/es 6.

7. Esquivel I, Perez J, Duncan Y, et al. Effect and safety of combination of interferón alpha-2b for negativization of SARS-CoV-2 viral RNA. medRxiv. 2020 [preprint]. [acceso: 22/09/2021]. Disponible en: Disponible en: https://www.medrxiv.org/content/10.1101/2020.07.29.20164251v2.full.pdf 7.

8. Perdigón Portieles CP, Hernández Toboso ML. Embarazo en tiempos de COVID-19, un acercamiento a la evidencia científica. Rev Cuba Obstetr Ginecol. 2020 [acceso: 22/09/2021]; 46(2): e634. Disponible en: Disponible en: http://www.revginecobstetricia.sld.cu/index.php/gin/article/view/634/575 8.